These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 30034528

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD.
    Zitomersky NL, Atkinson BJ, Fournier K, Mitchell PD, Stern JB, Butler MC, Ashworth L, Hauenstein S, Heiner L, Chuang E, Singh S, Bousvaros A.
    Inflamm Bowel Dis; 2015 Feb; 21(2):307-14. PubMed ID: 25569737
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. A review of six methods for monitoring infliximab concentrations and antibodies to infliximab
.
    Cao F, Cao H, Cao X.
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):571-580. PubMed ID: 28513424
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars.
    Ruiz-Argüello MB, Maguregui A, Ruiz Del Agua A, Pascual-Salcedo D, Martínez-Feito A, Jurado T, Plasencia C, Balsa A, Llinares-Tello F, Rosas J, Torres N, Martínez A, Nagore D.
    Ann Rheum Dis; 2016 Sep; 75(9):1693-6. PubMed ID: 26965981
    [Abstract] [Full Text] [Related]

  • 49. Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis.
    Nanda KS, Cheifetz AS, Moss AC.
    Am J Gastroenterol; 2013 Jan; 108(1):40-7; quiz 48. PubMed ID: 23147525
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies.
    Kopylov U, Mazor Y, Yavzori M, Fudim E, Katz L, Coscas D, Picard O, Chowers Y, Eliakim R, Ben-Horin S.
    Inflamm Bowel Dis; 2012 Sep; 18(9):1628-33. PubMed ID: 22038899
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Observer variability based on the strength of MR scanners in the assessment of lumbar degenerative disc disease.
    Cihangiroglu M, Yildirim H, Bozgeyik Z, Senol U, Ozdemir H, Topsakal C, Yilmaz S.
    Eur J Radiol; 2004 Sep; 51(3):202-8. PubMed ID: 15294326
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Infliximab levels and antibodies in IBD-related peripheral arthralgia.
    Levartovsky A, Ungar B, Yavzori M, Picard O, Fudim E, Eliakim R, Paul S, Roblin X, Ben-Horin S, Kopylov U.
    Int J Colorectal Dis; 2020 Jun; 35(6):1141-1148. PubMed ID: 32296932
    [Abstract] [Full Text] [Related]

  • 60. Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum.
    Wang SL, Ohrmund L, Hauenstein S, Salbato J, Reddy R, Monk P, Lockton S, Ling N, Singh S.
    J Immunol Methods; 2012 Aug 31; 382(1-2):177-88. PubMed ID: 22691619
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.